Literature DB >> 32308105

Long noncoding RNA LINC00339 promotes the oncogenicity of gastric cancer by regulating SRY-box 9 expression via sponging of microRNA-539.

Hui Zhao1, Hongyu Xiao2, Yi Lu2, Shen Liu3, Cheng Wang4.   

Abstract

Differential expression of LINC00339 is involved in the malignancy of multiple human cancer types. Nonetheless, the expression profile, functions, and potential mechanisms of action of LINC00339 in gastric cancer are yet to be fully elucidated. This study aimed at measuring LINC00339 expression in gastric cancer and examining the prognostic significance of LINC00339 in patients with gastric cancer. The detailed functions of LINC00339 with regard to the aggressive characteristics of gastric cancer cells and the underlying molecular mechanisms were investigated. Here, we found that LINC00339 expression was aberrantly high in gastric cancer and significantly associated with lymph node metastasis, invasive depth, and TNM stage. Patients with gastric cancer in a LINC00339 high-expression group showed shorter overall survival than patients in a LINC00339 low-expression group. A knockdown of LINC00339 suppressed gastric cancer cell proliferation, migration, and invasion and induced apoptosis in vitro and slowed tumor growth in vivo. In terms of the mechanism, LINC00339 was found to act as a molecular sponge on microRNA-539 (miR-539). SRY-box 9 (SOX9) was confirmed as a direct target gene of miR-539 in gastric cancer cells. An miR-539 knockdown attenuated the effects of the LINC00339 knockdown on the malignant characteristics of gastric cancer cells. Overall, LINC00339 plays a critical role in the malignancy of gastric cancer by regulating SOX9 via sponging of miR‑539. Our findings highlight the importance of the LINC00339-miR-539-SOX9 pathway in gastric cancer pathogenesis and may point to novel targets for the diagnosis, prognosis, and/or treatment of gastric cancer.

Entities:  

Keywords:  LINC00339; Microrna-539; SRY-box 9; gastric cancer

Year:  2020        PMID: 32308105      PMCID: PMC7217355          DOI: 10.1080/15384101.2020.1749404

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  46 in total

Review 1.  MicroRNAs: genomics, biogenesis, mechanism, and function.

Authors:  David P Bartel
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

Review 2.  MicroRNAs and the PTEN/PI3K/Akt pathway in gastric cancer (Review).

Authors:  Mingli Hu; Shixuan Zhu; Shengwei Xiong; Xingxing Xue; Xiaodong Zhou
Journal:  Oncol Rep       Date:  2019-01-10       Impact factor: 3.906

3.  Downregulation of long noncoding RNA LINC00460 expression suppresses tumor growth in vitro and in vivo in gastric cancer.

Authors:  Shuhua Zhang; Jianqun Xu; Hongjuan Wang; Hongrong Guo
Journal:  Cancer Biomark       Date:  2019       Impact factor: 4.388

4.  SOX9 expression and its methylation status in gastric cancer.

Authors:  Minhua Sun; Hiroshi Uozaki; Rumi Hino; Akiko Kunita; Aya Shinozaki; Tetsuo Ushiku; Takashi Hibiya; Kimiko Takeshita; Maya Isogai; Kenzo Takada; Masashi Fukayama
Journal:  Virchows Arch       Date:  2012-02-14       Impact factor: 4.064

5.  MiR-539 inhibits thyroid cancer cell migration and invasion by directly targeting CARMA1.

Authors:  Lixue Gu; Weiming Sun
Journal:  Biochem Biophys Res Commun       Date:  2015-07-20       Impact factor: 3.575

6.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

Authors:  Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-09-12       Impact factor: 508.702

7.  Long Non-coding RNA LINC00339 Stimulates Glioma Vasculogenic Mimicry Formation by Regulating the miR-539-5p/TWIST1/MMPs Axis.

Authors:  Junqing Guo; Heng Cai; Xiaobai Liu; Jian Zheng; Yunhui Liu; Wei Gong; Jiajia Chen; Zhuo Xi; Yixue Xue
Journal:  Mol Ther Nucleic Acids       Date:  2017-11-26       Impact factor: 8.886

8.  miR-539 inhibits FSCN1 expression and suppresses hepatocellular carcinoma migration and invasion.

Authors:  Yanping Liu; Wei Hong; Cancan Zhou; Zhengdong Jiang; Guanghui Wang; Guangbing Wei; Xuqi Li
Journal:  Oncol Rep       Date:  2017-04-03       Impact factor: 3.906

9.  Upregulation of microRNA-524-5p enhances the cisplatin sensitivity of gastric cancer cells by modulating proliferation and metastasis via targeting SOX9.

Authors:  Jing Wang; Xiaofeng Xue; Han Hong; Mingde Qin; Jin Zhou; Qing Sun; Hansi Liang; Ling Gao
Journal:  Oncotarget       Date:  2017-01-03

10.  Long noncoding RNA STXBP5-AS1 inhibits cell proliferation, migration, and invasion through inhibiting the PI3K/AKT signaling pathway in gastric cancer cells.

Authors:  Dongzhi Cen; Hu Huang; Liu Yang; Kai Guo; Jinshan Zhang
Journal:  Onco Targets Ther       Date:  2019-03-08       Impact factor: 4.147

View more
  1 in total

1.  Genetic analyses of gynecological disease identify genetic relationships between uterine fibroids and endometrial cancer, and a novel endometrial cancer genetic risk region at the WNT4 1p36.12 locus.

Authors:  Dylan M Glubb; Tracy A O'Mara; Pik Fang Kho; Sally Mortlock; Peter A W Rogers; Dale R Nyholt; Grant W Montgomery; Amanda B Spurdle
Journal:  Hum Genet       Date:  2021-07-15       Impact factor: 4.132

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.